B

Biocartis Tech Stack

Molecular oncology diagnostics platform with multi-cancer test portfolio

Medical Equipment Manufacturing Mechelen 201–500 employees Founded 2007 Privately Held

Biocartis operates a proprietary molecular diagnostics platform (Idylla) focused on cancer testing across seven tumor types. The tech stack is analytically weighted—R, Python, MATLAB, Minitab, and Spotfire alongside Salesforce—reflecting a science-heavy organization. Current hiring (13 open roles across support, engineering, finance, and healthcare) and active projects (product launches, distributor network expansion, lab network certification) signal expansion into new geographies and regulatory infrastructure maturation, while pain points around market access and regulatory compliance indicate the company is navigating the complexity of scaling clinical adoption across regions.

Tech Stack 12 technologies

Core StackSalesforce Python MATLAB DocuSign Microsoft Office Spotfire R Minitab Word Outlook Excel PowerPoint

What Biocartis Is Building

◆Challenges

Driving adoption of diagnostic solutions
Data management of post-market research studies
Compliance with labeling regulations
Technical accounting quality
Continuity of financial reporting
Reliability of financial reporting
Removing roadblocks
Market access challenges
Compliance with regulatory standards
System integration complexity

▲Active Projects

Investigator-initiated studies
Industry-sponsored studies
Post-marketing studies
Product launches in the region
Group consolidation process
Implementation of new ifrs standards
External audit preparation
New product launch
Certified laboratory network
Distributor network expansion

Hiring Activity

Accelerating15 roles · 6 in 30d

Department

Support

4

Engineering

3

Finance

1

Healthcare

1

Legal

1

Sales

1

Seniority

Mid

6

Senior

3

Director

1

Manager

1

Company intelligence

Find more companies like Biocartis by tech stack, pain points and active projects

Get started free

About Biocartis

Biocartis develops and commercializes the Idylla Platform, a proprietary molecular diagnostic system designed for oncology applications. The portfolio includes tests for melanoma, colorectal, lung, breast, thyroid, brain, and blood cancers, serving pathologists and oncology clinics. The company is headquartered in Mechelen, Belgium, and operates in the 201–500 employee range. Current operational focus spans product launches in new regions, certified laboratory network buildout, distributor channel expansion, and regulatory compliance infrastructure—indicating a transition from single-market to multi-country clinical adoption.

HeadquartersMechelen

Company Size201–500 employees

Founded2007

Hiring MarketsBelgium, Austria, Germany, Indonesia

Frequently Asked Questions

What cancer types does Biocartis test for?

Biocartis offers diagnostic tests for seven cancer types: melanoma, colorectal, lung, breast, thyroid, brain, and blood cancer, delivered through the Idylla Platform.